Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces
Mechanisms of neratinib resistance in <i>HER2</i>-mutant metastatic breast cancer
Improving HER2 testing reproducibility in HER2-low breast cancer
Cancer-associated fibroblasts as accomplices to confer therapeutic resistance in cancer
Tyrosine kinases in KMT2A/MLL-rearranged acute leukemias as potential therapeutic targets to overcome cancer drug resistance
Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach
Discovery of the inhibitor of DNA binding 1 as a novel marker for radioresistance in pancreatic cancer using genome-wide RNA-seq
Aberrant Notch signaling in gliomas: a potential landscape of actionable converging targets for combination approach in therapies resistance
Perspectives of metal-organic framework nanosystem to overcome tumor drug resistance
Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls
Cancer resistance to immunotherapy: What is the role of cancer stem cells?
Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review
The role of antiangiogenic monoclonal antibodies combined to EGFR-TKIs in the treatment of advanced non-small cell lung cancer with activating EGFR mutations: acquired resistance mechanisms and strategies to overcome them